These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 25453821)

  • 1. Synthesis and immunoregulatory activities of conjugates of a Toll-like receptor 7 inert ligand.
    Gao D; Liu Y; Li W; Zhong F; Zhang X; Diao Y; Gao N; Wang X; Jiang W; Jin G
    Bioorg Med Chem Lett; 2014 Dec; 24(24):5792-5795. PubMed ID: 25453821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and immunostimulatory activity of substituted TLR7 agonists.
    Akinbobuyi B; Wang L; Upchurch KC; Byrd MR; Chang CA; Quintana JM; Petersen RE; Seifert ZJ; Boquin JR; Oh S; Kane RR
    Bioorg Med Chem Lett; 2016 Sep; 26(17):4246-9. PubMed ID: 27476423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of the Immunostimulatory Activity of a TLR7 Ligand by Conjugation to Polysaccharides.
    Shinchi H; Crain B; Yao S; Chan M; Zhang SS; Ahmadiiveli A; Suda Y; Hayashi T; Cottam HB; Carson DA
    Bioconjug Chem; 2015 Aug; 26(8):1713-23. PubMed ID: 26193334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gold Nanoparticles Coimmobilized with Small Molecule Toll-Like Receptor 7 Ligand and α-Mannose as Adjuvants.
    Shinchi H; Yamaguchi T; Moroishi T; Yuki M; Wakao M; Cottam HB; Hayashi T; Carson DA; Suda Y
    Bioconjug Chem; 2019 Nov; 30(11):2811-2821. PubMed ID: 31560198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and Evaluation of Conjugates of Novel TLR7 Inert Ligands as Self-Adjuvanting Immunopotentiators.
    Gao D; Liu Y; Diao Y; Gao N; Wang Z; Jiang W; Jin G
    ACS Med Chem Lett; 2015 Mar; 6(3):249-53. PubMed ID: 25815141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and immunological characterization of toll-like receptor 7 agonistic conjugates.
    Chan M; Hayashi T; Kuy CS; Gray CS; Wu CC; Corr M; Wrasidlo W; Cottam HB; Carson DA
    Bioconjug Chem; 2009 Jun; 20(6):1194-200. PubMed ID: 19445505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conjugation of weak ligands with weak antigens to activate TLR-7: A step toward better vaccine adjuvants.
    Gao D; Zeng J; Wang X; Liu Y; Li W; Hu Y; Gao N; Diao Y; Wang Z; Jiang W; Chen J; Jin G
    Eur J Med Chem; 2016 Sep; 120():111-20. PubMed ID: 27187863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conjugation of a Small-Molecule TLR7 Agonist to Silica Nanoshells Enhances Adjuvant Activity.
    Huang CH; Mendez N; Echeagaray OH; Weeks J; Wang J; Vallez CN; Gude N; Trogler WC; Carson DA; Hayashi T; Kummel AC
    ACS Appl Mater Interfaces; 2019 Jul; 11(30):26637-26647. PubMed ID: 31276378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and immunostimulatory activity of sugar-conjugated TLR7 ligands.
    Baba A; Wakao M; Shinchi H; Chan M; Hayashi T; Yao S; Cottam HB; Carson DA; Suda Y
    Bioorg Med Chem Lett; 2020 Feb; 30(3):126840. PubMed ID: 31864800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like receptor 7 inactive ligands enhanced cytokine induction by conjugation to weak antigens.
    Gao D; Diao Y; Li W; Gao N; Liu Y; Wang Z; Jiang W; Jin G
    ChemMedChem; 2015 Jun; 10(6):977-80. PubMed ID: 25882779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptides conjugated to 2-alkoxy-8-oxo-adenine as potential synthetic vaccines triggering TLR7.
    Gential GPP; Hogervorst TP; Tondini E; van de Graaff MJ; Overkleeft HS; Codée JDC; van der Marel GA; Ossendorp F; Filippov DV
    Bioorg Med Chem Lett; 2019 Jun; 29(11):1340-1344. PubMed ID: 30952595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted Activation of Toll-Like Receptors: Conjugation of a Toll-Like Receptor 7 Agonist to a Monoclonal Antibody Maintains Antigen Binding and Specificity.
    Gadd AJ; Greco F; Cobb AJ; Edwards AD
    Bioconjug Chem; 2015 Aug; 26(8):1743-52. PubMed ID: 26133029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with 8-OH-modified adenine (TLR7 ligand)-allergen conjugates decreases T helper type 2-oriented murine airway inflammation.
    Nencini F; Pratesi S; Petroni G; Filì L; Cardilicchia E; Casini A; Occhiato EG; Calosi L; Bani D; Romagnani S; Maggi E; Parronchi P; Vultaggio A
    Immunology; 2015 Aug; 145(4):570-82. PubMed ID: 25930741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The TLR7 ligand 9-benzyl-2-butoxy-8-hydroxy adenine inhibits IL-17 response by eliciting IL-10 and IL-10-inducing cytokines.
    Vultaggio A; Nencini F; Pratesi S; Maggi L; Guarna A; Annunziato F; Romagnani S; Parronchi P; Maggi E
    J Immunol; 2011 Apr; 186(8):4707-15. PubMed ID: 21389257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of autoimmune inflammation by a TLR7 ligand regulating the innate immune system.
    Hayashi T; Yao S; Crain B; Chan M; Tawatao RI; Gray C; Vuong L; Lao F; Cottam HB; Carson DA; Corr M
    PLoS One; 2012; 7(9):e45860. PubMed ID: 23029281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TLR7/8 agonists activate a mild immune response in rabbits through TLR8 but not TLR7.
    Lai CY; Liu YL; Yu GY; Maa MC; Leu TH; Xu C; Luo Y; Xiang R; Chuang TH
    Vaccine; 2014 Sep; 32(43):5593-9. PubMed ID: 25131730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glyco-Nanoadjuvants: Sugar Structures on Carriers of a Small Molecule TLR7 Ligand Affect Their Immunostimulatory Activities.
    Shinchi H; Yuki M; Yamauchi T; Niimura M; Wakao M; Cottam HB; Hayashi T; Carson DA; Moroishi T; Suda Y
    ACS Appl Bio Mater; 2021 Mar; 4(3):2732-2741. PubMed ID: 35014312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redirection of allergen-specific TH2 responses by a modified adenine through Toll-like receptor 7 interaction and IL-12/IFN release.
    Filì L; Ferri S; Guarna F; Sampognaro S; Manuelli C; Liotta F; Cosmi L; Matucci A; Vultaggio A; Annunziato F; Maggi E; Guarna A; Romagnani S; Parronchi P
    J Allergy Clin Immunol; 2006 Aug; 118(2):511-7. PubMed ID: 16890779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of 8-oxoadenines with toll-like-receptor 7 and 8 activity.
    Bazin HG; Bess LS; Livesay MT; Li Y; Cybulski V; Miller SM; Johnson DA; Evans JT
    Bioorg Med Chem Lett; 2020 Mar; 30(6):126984. PubMed ID: 32001135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Additive melanoma suppression with intralesional phospholipid-conjugated TLR7 agonists and systemic IL-2.
    Hayashi T; Chan M; Norton JT; Wu CC; Yao S; Cottam HB; Tawatao RI; Corr M; Carson DA; Daniels GA
    Melanoma Res; 2011 Feb; 21(1):66-75. PubMed ID: 21030882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.